NCT04677361 2021-10-08
Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab
Fox Chase Cancer Center
Phase EARLY_PHASE1 Withdrawn
Clinical Trials
4 trialsNCT04220892 2020-07-31
Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma
Saint John's Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT03574220 2020-04-07
Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT03291353 2019-04-19
Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia
University of Pittsburgh
Phase EARLY_PHASE1 Withdrawn